Literature DB >> 9714712

FRG1, a gene in the FSH muscular dystrophy region on human chromosome 4q35, is highly conserved in vertebrates and invertebrates.

P K Grewal1, L C Todd, S van der Maarel, R R Frants, J E Hewitt.   

Abstract

The human FRG1 gene maps to human chromosome 4q35 and was identified as a candidate for facioscapulohumeral muscular dystrophy. However, FRG1 is apparently not causally associated with the disease and as yet, its function remains unclear. We have cloned homologues of FRG1 from two additional vertebrates, the mouse and the Japanese puffer fish Fugu rubripes, and investigated the genomic organization of the genes in the two species. The intron/exon structure of the genes is identical throughout the protein coding region, although the Fugu gene is five times smaller than the mouse gene. We have also identified FRG1 homologues in two nematodes; Caenorhabditis elegans and Brugia malayi. The FRG1 protein is highly conserved and contains a lipocalin sequence motif, suggesting it may function as a transport protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714712     DOI: 10.1016/s0378-1119(98)00334-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.

Authors:  T Rijkers; G Deidda; S van Koningsbruggen; M van Geel; R J L F Lemmers; J C T van Deutekom; D Figlewicz; J E Hewitt; G W Padberg; R R Frants; S M van der Maarel
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

2.  FRG1P-mediated aggregation of proteins involved in pre-mRNA processing.

Authors:  Silvana van Koningsbruggen; Kirsten R Straasheijm; Ellen Sterrenburg; Natascha de Graaf; Hans G Dauwerse; Rune R Frants; Silvère M van der Maarel
Journal:  Chromosoma       Date:  2006-11-14       Impact factor: 4.316

3.  Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.

Authors:  Qian Liu; Takako Iida Jones; Vivian W Tang; William M Brieher; Peter L Jones
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

4.  Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) expression and possible function in mouse tooth germ development.

Authors:  Kana Hasegawa; Hiroko Wada; Kengo Nagata; Hiroaki Fujiwara; Naohisa Wada; Hirotaka Someya; Yurie Mikami; Hidetaka Sakai; Tamotsu Kiyoshima
Journal:  J Mol Histol       Date:  2016-05-27       Impact factor: 2.611

5.  Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.

Authors:  Chia-Yun Jessica Sun; Silvana van Koningsbruggen; Steven W Long; Kirsten Straasheijm; Rinse Klooster; Takako I Jones; Michel Bellini; Lyne Levesque; William M Brieher; Silvère M van der Maarel; Peter L Jones
Journal:  J Mol Biol       Date:  2011-06-15       Impact factor: 5.469

Review 6.  Current status and future prospect of FSHD region gene 1.

Authors:  Arman Kunwar Hansda; Ankit Tiwari; Manjusha Dixit
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

Review 7.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

8.  FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.

Authors:  Ryan D Wuebbles; Meredith L Hanel; Peter L Jones
Journal:  Dis Model Mech       Date:  2009-04-21       Impact factor: 5.758

9.  Muscular dystrophy candidate gene FRG1 is critical for muscle development.

Authors:  Meredith L Hanel; Ryan D Wuebbles; Peter L Jones
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

Review 10.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.